Cargando…
Me‐too pharmaceutical products: History, definitions, examples, and relevance to drug shortages and essential medicines lists
We define a me‐too drug as a pharmacologically active compound that is structurally related to a first‐in‐class compound, regarded as belonging to the same therapeutic class as the original compound, and used for the same therapeutic purposes, but which may differ in some respects, such as specifici...
Autores principales: | Aronson, Jeffrey K., Green, A. Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576625/ https://www.ncbi.nlm.nih.gov/pubmed/32358800 http://dx.doi.org/10.1111/bcp.14327 |
Ejemplares similares
-
Withdrawn medicines included in the essential medicines lists of 136 countries
por: Charles, Onella, et al.
Publicado: (2019) -
Medicine, misconduct and confronting #MeToo
por: Bond, Eliza, et al.
Publicado: (2022) -
Comparison of essential medicines lists in 137 countries
por: Persaud, Nav, et al.
Publicado: (2019) -
Me, Too
por: Gyawali, Bishal
Publicado: (2016) -
The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland
por: Heiskanen, Kati, et al.
Publicado: (2017)